Tabuchi Keiji, Nakayama Masahiro, Nishimura Bungo, Hayashi Kentaro, Hara Akira
Department of Otolaryngology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8575, Japan.
Int J Otolaryngol. 2011;2011:638058. doi: 10.1155/2011/638058. Epub 2011 Jun 8.
Nasopharyngeal carcinoma (NPC) is a unique disease with a clinical presentation, epidemiology, and histopathology differing from other squamous cell carcinomas of the head and neck. NPC is an Epstein-Barr virus-associated malignancy with a marked racial and geographic distribution. Specifically, it is highly prevalent in southern China, Southeast Asia, and the Middle East. To date, most NPC patients have been diagnosed in the advanced stage, but the treatment results for advanced NPC are not satisfactory. This paper provides a brief overview regarding NPC, with the focus on the early detection of initial and recurrent NPC lesions.
鼻咽癌（NPC）是一种独特的疾病，其临床表现、流行病学和组织病理学与头颈部其他鳞状细胞癌不同。NPC是一种与爱泼斯坦-巴尔病毒相关的恶性肿瘤，具有明显的种族和地理分布。具体而言，它在中国南方、东南亚和中东地区高度流行。迄今为止，大多数NPC患者在晚期才被诊断出来，但晚期NPC的治疗效果并不理想。本文简要概述了NPC，重点是早期发现初发和复发性NPC病变。
